Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Trading Arrangement: Trading Arrangement [Axis] Maximum Maximum [Member] Research and development and out-of-pocket Percentage Of Research And Development Costs Percentage Of Research And Development Costs Statistical Measurement [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Document Fiscal Year Focus Document Fiscal Year Focus Adjustment to Compensation, Amount Adjustment to Compensation Amount Number of RSUs Number of PSUs Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Segment Reporting [Abstract] Common stock, par value $0.0001 per share, 500,000,000 shares authorized, 206,264,878 shares issued and outstanding at June 30, 2026 and 500,000,000 shares authorized, 203,940,353 shares issued and outstanding at March 31, 2026 Common Stock, Value, Issued Schedule of Restricted Stock Unit Awards Activity Share-Based Payment Arrangement, Restricted Stock and Restricted Stock Unit, Activity [Table Text Block] Restatement Determination Date Restatement Determination Date 2018 Equity Incentive Plan Equity Incentive Plan 2018 [Member] Equity Incentive Plan 2018. Cumulative milestone payments Cumulative Milestone Payments Cumulative Milestone Payments Amendment Flag Amendment Flag Current liabilities: Liabilities, Current [Abstract] Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Related Party Transactions Related Party Transactions Disclosure [Text Block] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Entity Address, State or Province Entity Address, State or Province Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross License Agreements [Abstract] License Agreements Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent PEO Total Compensation Amount PEO Total Compensation Amount Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Foreign currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Restricted stock units outstanding (in shares) Nonvested, beginning balance (in shares) Nonvested, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Upfront, non-refundable payment Upfront Payments Upfront payments Weighted-average common shares outstanding – basic (in shares) Weighted Average Number of Shares Outstanding, Basic Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Number of reportable segments Number of Reportable Segments Total current liabilities Liabilities, Current Capped value appreciation rights Capped value appreciation rights outstanding Capped Value Appreciation Rights [Member] Capped Value Appreciation Rights Entity Address, City or Town Entity Address, City or Town Issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Class of Stock [Axis] Class of Stock [Axis] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Recently Issued Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements, Policy [Policy Text Block] Net Loss per Common Share Earnings Per Share, Policy [Policy Text Block] Segment Reporting Segment Reporting [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Related Party [Axis] Related and Nonrelated Parties [Axis] Total other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Accrued Expenses And Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Research and Development Expenses Research and Development Expense, Policy [Policy Text Block] Document Period End Date Document Period End Date Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Capital contribution – stock-based compensation Adjustments To Additional Paid In Capital Contribution Share Based Compensation Adjustments to additional paid in capital contribution share based compensation. Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Preferred stock, outstanding (in shares) Preferred Stock, Shares Outstanding Stockholders' Equity Equity [Text Block] Security Exchange Name Security Exchange Name Granted (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Subsidiary or Equity Method Investee [Line Items] Subsidiary or Equity Method Investee [Line Items] Accumulated other comprehensive income Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Maximum number of shares issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Cash and Cash Equivalents [Line Items] Cash and Cash Equivalents [Line Items] Segment Information Segment Reporting, Policy [Policy Text Block] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Name Outstanding Recovery, Individual Name Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Purchase obligation, to be paid in 2027 Purchase Obligation, to be Paid, Year One Total liabilities Liabilities Trading Symbol Trading Symbol Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Unrecognized equity-based compensation related to unvested stock options and restricted stock units Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Company Selected Measure Name Company Selected Measure Name Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Related Party Transactions [Abstract] Related Party Transactions [Abstract] Cash flows from operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Weighted-average common shares outstanding – diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Purchase obligation, termination notice period Purchase Obligation, Termination Notice Period Purchase Obligation, Termination Notice Period Related Party Transaction [Line Items] Related Party Transaction [Line Items] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Other assets Increase (Decrease) in Other Noncurrent Assets Other general and administrative Other General and Administrative Expense Award Timing Predetermined Award Timing Predetermined [Flag] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock-based compensation APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Fair Value, Inputs, Level 1 Fair Value, Inputs, Level 1 [Member] Effective income tax rate Effective Income Tax Rate Reconciliation, Percent Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Nonvested, beginning balance (in dollars per share) Nonvested, ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value All Executive Categories All Executive Categories [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Depreciation on property and equipment Depreciation Plan Name [Domain] Plan Name [Domain] Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain] Unconditional Purchase Obligation, Category of Goods or Services Acquired [Domain] Antidilutive Securities [Axis] Antidilutive Securities [Axis] Beginning balance (in dollars per share) Ending balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Other unallocated research and development Other Unallocated Research And Development [Member] Other Unallocated Research And Development Segment Information Segment Reporting [Text Block] Dermatology diseases Dermatology Diseases [Member] Dermatology Diseases Expiration Date Trading Arrangement Expiration Date Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Location, Statement of Income, Balance [Axis] Location, Statement of Income, Balance [Axis] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Remaining Contractual Term (Years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted-Average Remaining Contractual Term Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock, authorized (in shares) Common Stock, Shares Authorized Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Security, Excluded EPS Calculation [Table] Issued in transaction (in shares) Sale of Stock, Number of Shares Issued in Transaction Common stock, par value (in dollars per share) Common Stock, No Par Value Reportable Segment Reportable Segment [Member] Reportable Segment Exercise Price Award Exercise Price Segment Reporting [Line Items] Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Preferred stock as converted Convertible Preferred Stock [Member] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Adoption Date Trading Arrangement Adoption Date Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Assets Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Insider Trading Policies and Procedures [Line Items] Stock options outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Accrued Expenses and Other Current Liabilities Accounts Payable and Accrued Liabilities Disclosure [Text Block] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Performance Shares Performance Shares [Member] Interest income, net Interest income, net Interest Income (Expense), Nonoperating Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Number of operating segments Number of Operating Segments Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Schedule Of Common Stock Reserved For Future Issuance [Line Items] Schedule Of Common Stock Reserved For Future Issuance [Line Items] Schedule of common stock reserved for future issuance. Restricted stock units outstanding Restricted stock units Restricted Stock Units (RSUs) [Member] Schedule of Potentially Dilutive Securities that Have Been Excluded from the Calculation of Diluted Net Loss Per Share Due to their Anti-Dilutive Effect Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Entity Central Index Key Entity Central Index Key All Adjustments to Compensation All Adjustments to Compensation [Member] Equity [Abstract] Equity [Abstract] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Income Statement [Abstract] Income Statement [Abstract] Stockholders’ equity: Equity, Attributable to Parent [Abstract] Neurological diseases Neurological Diseases [Member] Neurological Diseases Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Operating expenses: Operating Expenses [Abstract] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Schedule Of Common Stock Reserved For Future Issuance [Table] Schedule Of Common Stock Reserved For Future Issuance [Table] Schedule of common stock reserved for future issuance. Schedule of Fair Value Assumptions Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Number of Stock Options Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding [Roll Forward] City Area Code City Area Code Restricted stock units Restricted Stock [Member] Accumulated other comprehensive income (loss) AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Non-cash lease expense Operating Lease, Right-of-Use Asset, Periodic Reduction Name Forgone Recovery, Individual Name Remaining weighted average service period for recognition Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Weighted- Average Grant- Date Fair Value Weighted- Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Statement [Line Items] Statement [Line Items] Total assets Assets Preferred stock, issued (in shares) Preferred Stock, Shares Issued Common shares available for future issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Stock-based Compensation Share-Based Payment Arrangement [Policy Text Block] Research And Development Expense, Type [Domain] Research And Development Expense, Type [Domain] Research And Development Expense, Type [Domain] Schedule of Stock-based Compensation Expense Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Stock-Based Compensation Share-Based Payment Arrangement [Text Block] PEO PEO [Member] Beginning balance (in shares) Ending balance (in shares) Shares, Outstanding Cash and Cash Equivalents [Domain] Cash and Cash Equivalents [Domain] Stock Option Not Settled (Not Unvested) Stock Option Not Settled [Member] Stock Option Not Settled Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense Expired (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Stock based compensation expense Total stock-based compensation Share-Based Payment Arrangement, Expense Purchase price Sub Licensed Agreement Aggregate Purchase Price Sub licensed agreement aggregate purchase price. Preferred stock, conversion ratio Preferred Stock, Convertible, Conversion Ratio Stock options outstanding Stock Options And Stock Options Not Settled [Member] Stock Options And Stock Options Not Settled Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Stock options exercised (in shares) Exercised (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Cash and Cash Equivalents Cash and Cash Equivalents, Policy [Policy Text Block] Issued (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Schedule of Common Stock Reserved for Future Issuance Schedule Of Common Stock Reserved For Future Issuance [Table Text Block] Schedule of common stock reserved for future issuance. Payables and Accruals [Abstract] Payables and Accruals [Abstract] Personnel-related research and development Personnel-Related Research And Development [Member] Personnel-Related Research And Development Accumulated deficit Retained Earnings [Member] Total operating expenses Operating Expenses Money Market Funds Money Market Funds [Member] Forfeited (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Series A  preferred stock Series A Preferred Stock [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, outstanding (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Net loss per common share - diluted (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Other clinical and nonclinical Other Clinical and Nonclinical [Member] Other Clinical and Nonclinical Preferred stock Preferred Stock, Value, Outstanding Adjustments to reconcile net loss to net cash used in operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash flows from financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Prepaid expenses and other current assets Prepaid Expense, Current Forfeited (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Percentage of voting power of outstanding shares Percentage Of Voting Power Of Outstanding Shares Percentage of voting power of outstanding shares. Series A  preferred stock Preferred Stock [Member] Conversion of Series A preferred stock (in shares) Convertible Preferred Stock, Shares Reserved for Future Issuance Segment Reporting [Table] Segment Reporting [Table] Equity awards available for future grants (in shares) Common shares outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Issuance of common stock upon stock option exercises, cash not yet received Stock Issued Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Table] Additional Disclosures Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Number of subsidiaries in reorganization and transfer of intellectual property rights Number Of Subsidiaries, Reorganization And Transfer Of Intellectual Property Rights Number Of Subsidiaries, Reorganization And Transfer Of Intellectual Property Rights Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Current Fiscal Year End Date Current Fiscal Year End Date Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Contingent milestone payments Unrecorded Unconditional Purchase Obligation Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Stock options exercised and restricted stock units vested and settled Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Schedule of Nonvested Performance-Based Units Activity Schedule of Nonvested Performance-Based Units Activity [Table Text Block] Schedule of Stock Option Activity Share-Based Payment Arrangement, Option, Activity [Table Text Block] Weighted- Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Common stock, issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Purchase obligation, to be paid in 2028 Purchase Obligation, to be Paid, Year Two Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Related Party Related Party [Member] Entity Interactive Data Current Entity Interactive Data Current Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Entity Small Business Entity Small Business Comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Accounts payable Increase (Decrease) in Accounts Payable, Trade Risks and Uncertainties Risks And Uncertainties [Policy Text Block] Risks And Uncertainties [Policy Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other assets Other Assets, Noncurrent Document Type Document Type Fair Value as of Grant Date Award Grant Date Fair Value Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] Preferred Stock Preferred Stock Preferred Stock, Excluding Series A Preferred Stock [Member] Preferred Stock, Excluding Series A Preferred Stock Aggregate intrinsic value, exercisable Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Intrinsic Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Arrangement Duration Trading Arrangement Duration Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Research And Development Expense, Type [Axis] Research And Development Expense, Type [Axis] Research And Development Expense, Type Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Loss before provision for income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 10) Commitments and Contingencies License Agreement License Agreements Disclosure [Text Block] Material Agreements Disclosure [Text Block] Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Award vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Expired (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Remaining contractual term, exercisable (in years) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted-Average Remaining Contractual Term Award Type [Domain] Award Type [Domain] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Unrecorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] Unrecorded Unconditional Purchase Obligation by Category of Item Purchased [Axis] 2023 Inducement Plan Equity Inducement Plan 2023 [Member] Equity Inducement Plan 2023 Non-cash financing activity Supplemental Cash Flow Information [Abstract] Expected term, in years Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term PEO Name PEO Name Purchase commitment, period (within) Purchase Commitment, Period Purchase Commitment, Period Upon Achievement Of Development Regulatory And Sales Milestones Upon Achievement Of Development Regulatory And Sales Milestones [Member] Upon Achievement Of Development Regulatory And Sales Milestones [Member] Other segment items Segment Reporting, Other Segment Item, Amount 2019 Equity Incentive Plan Equity Incentive Plan 2019 [Member] Equity Incentive Plan 2019 Member Concentration of Credit Risk Concentration Risk, Credit Risk, Policy [Policy Text Block] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Exercised (in dollars per share) Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Cash and cash equivalents – beginning of period Cash and cash equivalents – end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Legal and other professional fees Accrued Professional Fees, Current Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Other expenses Other Accrued Liabilities, Current Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Maximum consideration License Agreement, Maximum Consideration License Agreement, Maximum Consideration Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Description of Business and Liquidity Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Personnel-related general and administrative Labor and Related Expense Percentage of common stock outstanding Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Related party transaction, amounts Related Party Transaction, Amounts of Transaction Net loss per common share - basic (in dollars per share) Earnings Per Share, Basic Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Award Type [Axis] Award Type [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Accumulated deficit Accumulated deficit Retained Earnings (Accumulated Deficit) Endocrine diseases Endocrine Diseases [Member] Endocrine Diseases Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Common stock Common Stock [Member] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Cover [Abstract] Cover [Abstract] Expected dividend yield Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate Equity Awards Adjustments Equity Awards Adjustments [Member] Restricted Stock Units Vested And Not Settled (Not Unvested) Restricted Stock Units Not Settled [Member] Restricted Stock Units Not Settled Total liabilities and stockholders’ equity Liabilities and Equity Liquidation amount per share (in dollars per share) Liquidation Amount Per Share liquidation amount per share. Stock options Stock Options Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Plan Name [Axis] Plan Name [Axis] Related Party [Domain] Related and Nonrelated Parties [Domain] Tabular List, Table Tabular List [Table Text Block] Additional paid-in capital Additional Paid in Capital Other income, net Other Nonoperating Income (Expense) Accrued expenses and other current liabilities Accrued expenses and other current liabilities Accrued Liabilities And Other Liabilities, Current Accrued Liabilities And Other Liabilities, Current Expected volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Weighted Average Volatility Rate Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Aggregate intrinsic value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period General and administrative General and Administrative Expense Preferred stock, authorized (in shares) Preferred Stock, Shares Authorized Accrued bonuses Accrued Bonuses, Current Adjustment to Compensation: Adjustment to Compensation [Axis] Class of Stock [Domain] Class of Stock [Domain] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Statement of Cash Flows [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accrued expenses and other current liabilities Increase (Decrease) In Accrued Liabilities And Other Liabilities, Current Increase (Decrease) In Accrued Liabilities And Other Liabilities, Current Name Measure Name Rheumatology diseases Rheumatology Diseases [Member] Rheumatology Diseases Income Taxes Income Tax Disclosure [Text Block] Schedule of Cash and Cash Equivalents [Table] Cash and Cash Equivalent [Table] Accounts payable Accounts Payable, Current Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Additional paid-in capital Additional Paid-in Capital [Member] Entity Filer Category Entity Filer Category Name Trading Arrangement, Individual Name Unrecognized compensation expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Cash and cash equivalents Cash and Cash Equivalent Company Selected Measure Amount Company Selected Measure Amount Units outstanding (in shares) Restricted stock units outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number Research and development expenses Accrued Research And Development Expenses Accrued Research And Development Expenses Entity Address, Address Line Two Entity Address, Address Line Two Stock options exercised and restricted stock units vested and settled (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Schedule of Stock by Class [Table] Stock, Class of Stock [Table] Contractual costs related to batoclimab program discontinuation Accrued Contractual Costs Related To Batoclimab Program Discontinuation Accrued Contractual Costs Related To Batoclimab Program Discontinuation Current assets: Assets, Current [Abstract] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Vested (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Provision for income taxes Income Tax Expense (Benefit) Purchase obligation Purchase Obligation Award Timing Method Award Timing Method [Text Block] Net change in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Grants in period, fair value Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value Share-Based Compensation Arrangement By Share Based Payment Award, Equity Instruments Other Than Options, Grants In Period, Fair Value Research and development Research and Development Expense (Excluding Acquired in Process Cost) Net loss Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Statement [Table] Statement [Table] Restatement Determination Date: Restatement Determination Date [Axis] Proceeds from stock options exercised Proceeds from Stock Options Exercised Exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Cash and Cash Equivalents [Axis] Cash and Cash Equivalents [Axis] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block]